Bing Yao1, Simon Hametner2, Peter
  van Gelderen1, Hellmut Merkle1, Fredric Cantor3,
  Henry McFarland3, Hans Lassmann2, Jeff H. Duyn1,
  Francesca Bagnato3
1AMRI, NINDS, National Institutes of
  Health, Bethesda, MD, United States; 2Centre for Brain Research,
  Medical University, Vienna, Austria; 3NIB, NINDS, National
  Institutes of Health, Bethesda, MD, United States
Focal
  cortical grey matter lesions (CLs) are an important component of multiple sclerosis
  (MS) pathology. However, detecting cortical lesions in MS using MRI poses
  challenges. MRI at ultra-high field strengths such as 7 Tesla has the
  potential to superbly enhance MS-induced CLs visibility. In this study, we
  applied ultra-high resolution R2* maps to detect and evaluate cortical
  lesions and their subtypes and the MRI results were compared with the
  pathology analysis.
Keywords